<DOC>
	<DOC>NCT00623363</DOC>
	<brief_summary>The purpose of this study is to obtain preliminary information on the effect of piclozotan on motor complications associated with Parkinson's Disease.</brief_summary>
	<brief_title>Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Piclozotan</mesh_term>
	<criteria>Main Idiopathic Parkinson's disease for at least 5 years Presence of motor fluctuations and dyskinesia Stable regimen of levodopa/carbidopa for 30 days At least 25% response/improvement in UPDRS part III scores after dosing with regular PD medications MMSE score of 25 or higher Main Atypical or secondary parkinsonism. Prior use of neuroleptic agents. History of intracranial procedures for PD. Active psychosis. History of drug or alcohol abuse in past 12 months. Cardiac conduction system abnormality. Predisposing medical condition that causes nausea or vomiting or routine use of an antiemetic.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Parkinson's Disease</keyword>
	<keyword>motor complications</keyword>
	<keyword>dyskinesia</keyword>
	<keyword>Motor complications associated with Parkinson's</keyword>
</DOC>